German company joimax has introduced a new iLESSYS biportal interlaminar endoscopic surgical system to treat spinal disorders.

The iLESSYS biportal system is suitable for bimanual surgical procedures.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Expanding the company’s endoscopic offerings, the iLESSYS biportal for unilateral biportal endoscopy (UBE) comes with a feature wherein the instrument working port can be separated from the endoscope, thereby enabling unrestricted relative movement between the two components.

Besides featuring a special triangulation tool for simplifying the access triangulation of two ports, the system has biportal-specific working tubes with inbuilt irrigation outflow control for accurate water management.

The system also features larger and more advanced tools for effective tissue ablation and resection.

joimax Group CEO and founder Wolfgang Ries said: “The system will be part of the ESPINEA training and education programme and will be fully implemented in the workshop courses by the end of the year.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“We´ve already lined up a range of surgical faculty in Europe (Dr Ralf Wagner, Dr Maxime Challali, Dr Raed Abohussein, Dr Miguel Loureiro), in the Americas (Dr Peter Derman, Dr Meng Huang, Dr Javier Quillo-Olvera) and in Asia (Prof Si-Young Park, Dr Junseok Bae) among others in each of these regions, with many more to follow.”

Founded in 2001, joimax develops and sells complete systems for complete-endoscopic and minimally invasive spinal surgery.

The company offers TESSYS (transforaminal), iLESSYS (interlaminar) and CESSYS (cervical) for decompression procedures, MultiZYTEfor facet and sacroiliac joint pain treatment, EndoLIF and Percusys for minimally invasive endoscopically assisted stabilisation.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact